Latest Post

August 06, 2020

West's Integrated Solutions - Reducing Risks

In 2011, the US FDA issued an advisory regarding the potential formation of glass lamellae in vials containing injectable drugs. This was in response to several drug recalls in 2010-11. The number of glass-related drug recalls has since declined greatly. This no doubt is due to key actions taken by pharmaceutical manufacturers before the drug goes to market, even during the development phases.
JiaMin Boo

Jia Min Boo

Technical Account Specialist, TCS, Jurong

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    By Your Side for Innovation

    November 13, 2019

    By Your Side for Speed to Market

    Chris Ryan

    Chris Ryan

    VP & GM, Global Generics

    Intern Final Showcase

    August 16, 2019

    2019 Ambassador Interns Host Final Showcase Event

    Santina Zouras

    Santina Zouras

    Global Communications Intern

    Intern Philanthropy

    August 09, 2019

    West Interns Volunteer at Thorncroft Equestrian Center

    Santina Zouras

    Santina Zouras

    Global Communications Intern

    CPhI China Tradeshow

    June 20, 2019

    West Helps Simplify the Journey™ in China

    Jessie Zhang

    Jessie Zhang

    Manager, Global Communications, AP

    SmartDose In-Use

    May 07, 2019

    The Impact Poor Formulations Have on Drug Development Programs

    Victoria Morgan

    Victoria Morgan

    Director, Segment Marketing, Global Biologics

    Introducing Integrated Solutions

    May 02, 2019

    FDA Guidance Affecting cGMP Compounding Pharmacies (503Bs)

    Amy Kim

    Amy Kim

    Sr. Specialist, Scientific Communications, SA & TS

    Stoppers

    April 23, 2019

    Selecting the Right Package for a Drug Product

    Page McAndrew

    T. Page McAndrew

    Director, Scientific Communications

    Load more